(Q56770154)
Statements
Impact of point-of-care testing for CYP2C19 on platelet inhibition in patients with acute coronary syndrome and early dual antiplatelet therapy in the emergency setting (English)
Athanasios Karathanos
Tobias Geisler
Fabian Stimpfle
Janina Metzger
Dominik Rath
Karin Müller
Elli Tavlaki
Elke Schäffeler
Stefan Winter